A portable microfluidic platform for rapid molecular diagnostic testing of patients with myeloproliferative neoplasms

The ability to simultaneously detect JAK2 V617F and MPL W515K/L mutations would substantially improve the early diagnosis of myeloproliferative neoplasms (MPNs) and decrease the risk of arterial thrombosis. The goal of this study is to achieve a point of care testing platform for simultaneous analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hua, zhang, Xinju, Xu, Xiao, Zhang, Qunfeng, Wang, Hengliang, Li, Dong, Kang, Zhihua, Wu, Zhiyuan, Tang, Yigui, An, Zhenhua, Guan, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561050/
https://www.ncbi.nlm.nih.gov/pubmed/28819248
http://dx.doi.org/10.1038/s41598-017-08674-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561050/
https://www.ncbi.nlm.nih.gov/pubmed/28819248
http://dx.doi.org/10.1038/s41598-017-08674-8

Ejemplares similares